Researchers have identified a potential cause of hyperhidrosis, a condition characterized by excessive sweating unrelated to heat or exercise, which could lead to the development of more effective treatments. The findings suggest that for some individuals, the condition may originate from a genetic mutation affecting the nerves that control sweat glands, rather than being solely a disorder of the sweat glands themselves.
Hyperhidrosis affects an estimated 15.3 million Americans, primarily between the ages of 18 and 39. Patients with the condition often experience sweating so profuse that it soaks through clothing or drips from their hands, necessitating frequent changes and significantly disrupting daily life. The condition is most common in adults between the ages of 18 and 39, and risk factors include a family history of the condition, certain medications, or underlying medical issues.
Genetic Mutation Identified
A study published in Science Advances by researchers at Johns Hopkins University examined DNA from families with inherited hyperhidrosis. They discovered that approximately one-fifth of individuals with the condition carried a mutation in the SCN10A gene, which affects the sodium channel NaV1.8. This channel is located in nerves that regulate sweat gland activity.
To validate their findings, scientists created mice with the identified mutation. These mice exhibited excessive sweating, mirroring the human condition and establishing a direct correlation between the genetic anomaly and hyperhidrosis. Further investigation revealed that the NaV1.8 channel plays a role in sympathetic nerve cells, making them overactive and consequently leading to increased sweat production.
"We found that this mutation essentially turns up the volume on the nerve signals that stimulate sweating," said Dr. Malcom Brock, a surgeon who led the research. "That insight gives us a specific target to pursue for future therapies."
New Avenues for Treatment
Historically, hyperhidrosis has been managed with treatments aimed at controlling the symptom of excessive sweating once it occurs. These typically begin with prescription antiperspirants and can escalate to oral medications, botulinum toxin injections, or device therapy, depending on severity.
However, these existing treatments do not address the underlying biological mechanism. "By developing an understanding of how to treat hyperhidrosis closer to its origin, researchers will be able to direct future therapies toward correcting the abnormal nerve pathways identified by this research," explained Dr. Paul Gross, a primary care physician. He added that while current treatments provide relief, they do not resolve the cause, often requiring lifelong management.
The new research opens a path toward developing therapies that target the overactive nerves directly. While considerable work remains before these novel treatments become available, this study marks a significant initial step toward more targeted and potentially long-term solutions for individuals suffering from hyperhidrosis.